Virtu Financial’s China SXT Pharmaceuticals SXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24K | Buy |
+13,970
| New | +$24K | ﹤0.01% | 1238 |
|
|
2024
Q3 | – | Sell |
-3,951
| Closed | -$34K | – | 1867 |
|
|
2024
Q2 | $34K | Buy |
+3,951
| New | +$34K | ﹤0.01% | 959 |
|
|
2023
Q2 | – | Sell |
-197
| Closed | -$11K | – | 2018 |
|
|
2023
Q1 | $11K | Sell |
197
-249
| -56% | -$13.9K | ﹤0.01% | 1339 |
|
|
2022
Q4 | $48K | Buy |
+446
| New | +$48K | 0.01% | 1093 |
|
|
2022
Q3 | – | Sell |
-74
| Closed | -$26K | – | 2224 |
|
|
2022
Q2 | $26K | Buy |
74
+51
| +222% | +$17.9K | ﹤0.01% | 1279 |
|
|
2022
Q1 | $25K | Buy |
23
+12
| +109% | +$13K | ﹤0.01% | 1265 |
|
|
2021
Q4 | $28K | Buy |
11
+2
| +22% | +$5.09K | ﹤0.01% | 1463 |
|
|
2021
Q3 | $39K | Buy |
+9
| New | +$39K | ﹤0.01% | 1307 |
|
|
2020
Q4 | – | Sell |
-1
| Closed | -$5K | – | 1778 |
|
|
2020
Q3 | $5K | Buy |
+1
| New | +$5K | ﹤0.01% | 970 |
|
|
2019
Q2 | – | Sell |
-2
| Closed | -$182K | – | 1835 |
|
|
2019
Q1 | $182K | Buy |
+2
| New | +$182K | 0.01% | 1015 |
|